NDC Compounded Drug 70092-443-43 Lidocaine Hydrochloride
Solution Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Lidocaine Hydrochloride
NDC crossover of Lido 1% Bicarb Pf 1 Ml-3 Ml Syr with NDC 70092-443 a human compounded drug with other similar products matching the same substance name (Lidocaine Hydrochloride) and the same administration route (intravenous) or dosage form (solution).
| NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
|---|---|---|---|---|---|---|
| 69194-740-01 | 740 Lidocaine Hcl 4% Bottle | Lidocaine Hcl | 3 mL in 1 BOTTLE, DROPPER | Solution | Ophthalmic | Pine Pharmaceuticals Llc |
| 69194-740-01 | 740 Lidocaine Hcl 4% Bottle | Lidocaine Hcl | 3 mL in 1 BOTTLE, DROPPER | Solution | Ophthalmic | Pine Pharmaceuticals Llc |
| 70092-175-46 | Lidocaine 1% Bicarb 10 Ml Syr Pf | Lidocaine 1% Bicarb 10 Ml Syr Pf | 10 mL in 1 SYRINGE | Solution | Infiltration | Quva Pharma, Inc. |
| 70092-175-46 | Lidocaine 1% Bicarb 10 Ml Syr Pf | Lidocaine 1% Bicarb 10 Ml Syr Pf | 10 mL in 1 SYRINGE | Solution | Infiltration | Quva Pharma, Inc. |
| 71286-6006-1 | Lidocaine 2% | Lidocaine 2% | 5 mL in 1 SYRINGE | Solution | Intravenous | Central Admixture Pharmacy Services, Inc. |
| 72196-6006-1 | Lidocaine 2% | Lidocaine 2% | 5 mL in 1 SYRINGE | Solution | Intravenous | Central Admixture Pharmacy Services, Inc. |
Frequently Asked Questions
What is the NDC number assigned to Lidocaine 2%?
Lidocaine 2% was assigned by its manufacturer with NDC product code 70092-443. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Lidocaine 2%?
The NDC package code 70092-443-43 was assigned to a 1 mL in 1 SYRINGE of lidocaine hydrochloride administered intravenous via solution.
Who manufactures this product?
Lidocaine 2% is manufactured by an outsourced facility and labeled by Quva Pharma, Inc.. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 6 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Pine Pharmaceuticals LLC, QuVa Pharma, Inc. and Central Admixture Pharmacy Services, Inc. with NDC product codes 69194-740-01, 69194-740-01, 70092-175-46, 70092-175-46, 71286-6006-1 and 72196-6006-1.